Selective Cytostatic and Cytotoxic Anticancer Effects of Bisfunctional Agents: A Strategy for the Design of DNA Binding Agents

Jaroslaw Spychala

doi:https://doi.org/10.1016/j.canlet.2009.02.026

Selective Cytostatic and Cytotoxic Anticancer Effects of Bisfunctional Agents: A Strategy for the Design of DNA Binding Agents

Abstrakt

Various agents have been synthesized and proved useful for the National Cancer Institute's anticancer testing as potential new drugs, but most agents suffer side effects from their limited selectivity against cancer cells over healthy ones. Therefore, this paper attempts to describe drugs in terms of the level of tumor cell selectivity which they possess to define the features of mols. that are essential for useful cytotoxicity. Selected cyclic amidinothymine analogs (NSC 697864, NSC 697865, and NSC 697869) have nanomolar inhibitory activities against leukemia cell lines: CCRF-CEM, HL-60(TB), while bisfunctional cancer fighters NSC 702408 and NSC 702409, showing larger nos. of cytostatic and cytotoxic effects, in an extended conformation would probably adopt a similar to NSC 715653 conformation leaving both opposite H-bond donor groups at the same distance to interact with DNA in a similar way. Such specific interactions (cell line selectivity to unique mutated patterns) lower considerably the obsd. dose-response concns. This in vitro selectivity is shown to translate into in vivo efficacy indicated by the inflection in the cumulative testing curve.

Cytowania

Autor (1)

Jaroslaw Spychala dr

Cytuj jako

Pełna treść

pełna treść publikacji nie jest dostępna w portalu

pełna treść artykułu zobacz w serwisie zewnętrznym otwiera się w nowej karcie

Słowa kluczowe

Informacje szczegółowe

Kategoria:: Publikacja w czasopiśmie
Typ:: Publikacja w czasopiśmie
Opublikowano w:: CANCER LETTERS nr 281, wydanie 2, strony 203 - 212,
ISSN: 0304-3835
Rok wydania:: 2009
Opis bibliograficzny:: Jaroslaw Spychala, Selective Cytostatic and Cytotoxic Anticancer Effects of Bisfunctional Agents: A Strategy for the Design of DNA Binding Agents, CANCER LETTERS, vol. 281(2), pages 203-212, 2009.
DOI:: Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) https://doi.org/10.1016/j.canlet.2009.02.026
Weryfikacja:: Brak weryfikacji